Aida Pharmaceuticals (OTCPK:AIDA) - Stock Price, News & Analysis

AIDA Stock Overview

Engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China. More details

AIDA fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($8K)

Latest financial reports are more than a year old

Shares are highly illiquid

Aida Pharmaceuticals, Inc. Competitors

Lucy Scientific Discovery

OTCPK:LSDI.F

US$882.0

Hero Technologies

OTCPK:HENC

US$563.0

CBD Life Sciences

OTCPK:CBDL

US$1.4m

Veritas Farms

OTCPK:VFRM

US$81.9k

Price History & Performance

Summary of all time highs, changes and price drops for Aida Pharmaceuticals
Historical stock prices
Current Share Price	US$0.0003
52 Week High	US$0.0003
52 Week Low	US$0.0002
Beta	0
11 Month Change	50.00%
3 Month Change	50.00%
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	-97.35%
Change since IPO	-99.98%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	AIDA	US Pharmaceuticals	US Market
7D	0%	3.4%	1.6%
1Y	n/a	14.2%	32.3%

Return vs Industry: Insufficient data to determine how AIDA performed against the US Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how AIDA performed against the US Market.

Price Volatility

Is AIDA's price volatile compared to industry and market?
AIDA volatility
AIDA Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	10.0%
Market Average Movement	6.3%
10% most volatile stocks in US Market	16.2%
10% least volatile stocks in US Market	3.1%

Stable Share Price: AIDA's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine AIDA's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1999	n/a	Biao Jin	n/a

Aida Pharmaceuticals, Inc., together with its subsidiaries, engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China. It offers antibiotics, cardiovascular, and anti-cancer drugs. The company provides its products in the form of powder for injection; and liquid for intravenous injection, capsule, tablet, and ointment.

Aida Pharmaceuticals, Inc. Fundamentals Summary

How do Aida Pharmaceuticals's earnings and revenue compare to its market cap?
AIDA fundamental statistics
Market cap	US$8.10k
Earnings (TTM)	-US$2.18m
Revenue (TTM)	US$40.51m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is AIDA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AIDA income statement (TTM)
Revenue	US$40.51m
Cost of Revenue	US$18.20m
Gross Profit	US$22.30m
Other Expenses	US$24.48m
Earnings	-US$2.18m

Last Reported Earnings

Sep 30, 2008

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did AIDA perform over the long term?

See historical performance and comparison